AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-89882786/cox-2-inhibitors-face.html" title="Facts and information about COX-2 inhibitors face marketing challenges. (Newswire).(Brief Article)">COX-2 inhibitors face marketing challenges. (Newswire).(Brief Article)</a>

Close Set up an RSS feed that alerts you when new articles from Medical Marketing & Media are available.

Frequently asked questions about RSS feeds

COX-2 inhibitors face marketing challenges. (Newswire).(Brief Article)

Medical Marketing & Media

| July 01, 2002 | COPYRIGHT 1999 CPS Communications, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

A differentiation between the two leading COX-2 inhibitors, Celebrex and Vioxx, has been established after more than two years on the market, but the changes may lead to gastric distress for marketers: the labeling changes focus on limitations rather than attributes.

On the basis of a new study, with the acronym "CLASS," the FDA has concluded that Celebrex showed no clear advantage over ibuprofen or diclofenac, in gastric safety, thereby eliminating its chief marketing claim. New labeling for Celebrex, co-marketed by Pharmacia and Pfizer, states that differences in the incidence of complicated ulcers and safety advantage in upper GI events are not statistically…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


DAGENS INDUSTRI: Celebrex setback for Pharmacia in US.: News wire article from: Chemical Business Newsbase May 30, 2001 700+ words
...that patients taking Pharmacia's antirheumatic drug Celebrex or its competitor...of the stock market. Celebrex is Pharmacia's biggest product...the European launch of Celebrex. This setback for Pharmacia is accompanied by the...


PHARMA JAPAN: FDA approves Pharmacia's Celebrex for acute pain relief.: News wire article from: Chemical Business Newsbase November 13, 2001 700+ words
...Administration approved Celebrex (celecoxib, Pharmacia Corp) for acute pain...marketed in the US by Pharmacia and Pfizer Inc. In 2000, Celebrex had global sales of...developed in Japan by Pharmacia and Yamanouchi.


Celebrex successor sought.(Pharmacia Corp.)(Illustration): Magazine article from: Chain Drug Review April 23, 2001 700+ words
Pharmacia Corp. has asked the FDA to approve valdecoxib as a successor to Celebrex, its popular arthritis drug. The agency is expected to act on the application within a year.


La Tribune Desfosses: Novartis claims new antiarthritic more effective than...: News wire article from: Asia Africa Intelligence Wire October 2, 2002 700+ words
...details of a clinical study that shows its new Prexige antiarthritic to be significantly more effective than Celebrex marketed by Pharmacia. Prexige is one of several new Novartis products undergoing phase III clinical trials. Some analysts suggest...


New Study Validates Safety of Pharmacia Corporation's Celebrex on Stroke, Heart...: Press release article from: PR Newswire April 28, 2000 700+ words
...is not the case for Pharmacia Corporation's innovative...specific inhibitor, Celebrex(R) (celecoxib...common side effects of Celebrex were dyspepsia, diarrhea...mild to moderate. Celebrex is co-promoted by Pharmacia Corporation and Pfizer...


Pharmacia/Pfizer: Celebrex Safety Profile is Well-Established.: Press release article from: PR Newswire August 22, 2001 700+ words
...PRNewswire/ -- Pharmacia and Pfizer...and safety of Celebrex (celecoxib...patients who take Celebrex for symptoms...diseases. Pharmacia and Pfizer...effects of CELEBREX were dyspepsia...marketed by Pharmacia Corporation...


Celebrex OK with aspirin.(Pharmacia disputes database report)(Brief Article): Magazine article from: Chemist & Druggist June 15, 2002 700+ words
...highlighting a major interaction between Celebrex (celecoxib and aspirin, Pharmacia has issued a statement to clarify the situation. Celebrex does not interact with aspirin...prophylaxis. For more information: Pharmacia Tel: 01908 661101. Copyright...


Drug account could dull pain ; Pharmacia and Pfizer's Celebrex successor will...: Magazine article from: Advertising Age Goetzl, David May 21, 2001 700+ words
...Co-marketers Pharmacia Corp. and Pfizer...blockbuster arthritis drug Celebrex. The drug, known...roster shops of both Pharmacia and Pfizer. Bcom3...Chicago, has handled Celebrex since its launch...for etoricoxib. Pharmacia's Mr. Buchholz...declined comment on how Celebrex and ...


Sidley Client Pharmacia Prevails in Celebrex(R) Patent Infringement Case.: Press release article from: PR Newswire March 17, 2003 700+ words
...research of the Pharmacia discovery team that actually invented Celebrex(R)," said Sidley...worked with the many Pharmacia witnesses on the discovery team for Celebrex(R), the patented...team representing Pharmacia, Searle and Monsanto...


Pharmacia modifies Celebrex ad after FDA objection.(Brief Article): Magazine article from: Drug Store News January 15, 2001 700+ words
Pharmacia modified its Celebrex direct-to-consumer TV ads after the Food and Drug Administration...effective than has been demonstrated by substantial evidence." Pharmacia changed the audio statement to "Celebrate, celebrate. Come on...

For more facts and information, see all results

Source: HighBeam Research, COX-2 inhibitors face marketing challenges. (Newswire).(Brief Article)

The AccessMyLibrary advertising network includes: